Company Overview of Pancreatic Cancer Action Network, Inc.
Key Executives for Pancreatic Cancer Action Network, Inc.
Chief Executive Officer and President
Vice President of Scientific and Medical Affairs
Compensation as of Fiscal Year 2013.
Pancreatic Cancer Action Network, Inc. Key Developments
The Pancreatic Cancer Action Network Announces Appointments to Scientific Advisory Board
Aug 13 13
The Pancreatic Cancer Action Network to welcome three new members to its prestigious Scientific Advisory Board: Sunil Hingorani, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA; Kimberly Kelly, PhD, University of Virginia, Charlottesville, VA; and Steven Leach, MD, Johns Hopkins University, Baltimore, MD. Vincent Picozzi, MD, Virginia Mason Medical Center, Seattle, WA, was appointed chair of the organization's Medical Advisory Board. Dr. Hingorani played a lead role in the development of the first genetically engineered mouse model of pancreatic cancer that accurately recapitulates the human disease. Dr. Kelly's work focuses on imaging techniques to improve early detection and diagnosis of pancreatic cancer. Based on findings funded by organization, Dr. Kelly has cofounded a biotechnology company and is currently conducting an early-phase clinical trial to test her noninvasive early detection biomarker. Dr. Leach looks at the early development of the normal pancreas to provide clues to how tumors arise. He also studies the earliest stages of pancreatic cancer initiation to discover better methods to detect and treat the disease before it has progressed to become more aggressive. Dr. Picozzi has been the principal investigator on a number of other clinical trials in pancreatic cancer. Dr. Picozzi joined the Pancreatic Cancer Action Network's Medical Advisory Board in 2008.
The Pancreatic Cancer Action Network Announces Executive Changes
Jul 9 13
The Pancreatic Cancer Action Network announced Laurie MacCaskill has been appointed Chair of the National Board of Directors of the organization, effective July 1. MacCaskill is the first pancreatic cancer patient to hold this position. The organization has also appointed Jeanne Ruesch to Vice Chair effective July 1. Ruesch serves on the board in honor of her late husband, Otto J. Ruesch.
Pancreatic Cancer Action Network, Inc. Announces Appointment of Members to Medical Advisory Board
Feb 5 13
Pancreatic Cancer Action Network, Inc. has named four new members to the organization's medical advisory board. The newest advisors are clinicians in the field of pancreatic cancer: Joseph M. Herman, MD, MSc, Johns Hopkins University, George A. Fisher Jr., MD, PhD, Stanford University, James Farrell, MD, Yale University and Philip Agop Philip, MD, PhD, Karmanos Cancer Center.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|